EAPCI立场声明:COVID-19疫情期间急性冠脉综合征的侵入性管理
该立场声明由欧洲经皮心血管介入协会(EAPCI)与急性心血管监护协会(ACVC)任命的介入心脏病学家和急性心脏监护专家小组制定,纳入欧洲最早且受疫情影响最严重地区的经验。声明针对确诊或疑似COVID-19感染的ST段抬高型和非ST段抬高型ACS患者,提出调整后的诊断与治疗算法,以在疫情挑战下适配循证方案。同时阐述ACS网络重组(枢纽与辐射医院重新分配)以及急诊室和心脏单元院内重组的必要性,并给出导管室重组和侵入性操作医护人员防护措施的指导。
要点
- 声明针对确诊或疑似COVID-19感染的ST段抬高型和非ST段抬高型ACS患者,提出调整后的诊断与治疗算法。
- 需对ACS网络进行重组,重新分配枢纽与辐射医院,并重组院内急诊室和心脏单元。
- 提供导管室重组指导及侵入性操作中医护人员防护措施的建议。
- 制定小组由EAPCI和ACVC任命的介入心脏病学家与急性心脏监护专家组成,纳入欧洲最早且受疫情影响最严重地区的经验。
适用人群与场景
- 确诊或疑似COVID-19感染、表现为ST段抬高型或非ST段抬高型ACS的患者。
处置流程与药物剂量
- 对确诊或疑似COVID-19感染的ST段抬高型和非ST段抬高型ACS患者,采用声明提出的调整后诊断与治疗算法。
- 重组ACS网络,重新分配枢纽与辐射医院。
- 对院内急诊室和心脏单元进行重组。
- 对导管室进行重组,并采取侵入性操作中医护人员的防护措施。
研究设计与关键结果
- 制定小组由EAPCI和ACVC任命的介入心脏病学家和急性心脏监护专家组成,纳入欧洲最早且受疫情影响最严重地区的经验。
- 声明描述了确诊或疑似COVID-19感染的ST段抬高型和非ST段抬高型ACS患者的各种临床场景及管理算法。
- 声明提供了来自多个欧洲国家的ACS网络重组、急诊室和心脏单元院内重组的示例。
证据类型、等级与局限
- 证据类型:学会立场声明(EAPCI与ACVC任命专家小组制定)。
- 局限:原文未报告局限性
对床旁实践的改变
- 在COVID-19疫情期间,对确诊或疑似感染的ACS患者按声明提出的调整后诊断与治疗算法进行侵入性管理。
- 按声明建议重组ACS网络(枢纽与辐射医院重新分配)及院内急诊室、心脏单元和导管室。
- 对参与侵入性操作的医护人员采取声明给出的防护措施。
指南或共识出处
- EAPCI Position Statement on Invasive Management of Acute Coronary Syndromes during the COVID-19 pandemic(欧洲经皮心血管介入协会,发表于Eur Heart J)
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
The coronavirus disease 2019 (COVID-19) pandemic poses an unprecedented challenge to healthcare worldwide. The infection can be life threatening and require intensive care treatment. The transmission of the disease poses a risk to both patients and healthcare workers. The number of patients requiring hospital admission and intensive care may overwhelm health systems and negatively affect standard care for patients presenting with conditions needing emergency interventions. This position statements aims to assist cardiologists in the invasive management of acute coronary syndrome (ACS) patients in the context of the COVID-19 pandemic. To that end, we assembled a panel of interventional cardiologists and acute cardiac care specialists appointed by the European Association of Percutaneous Cardiovascular Interventions (EAPCI) and from the Acute Cardiovascular Care Association (ACVC) and included the experience from the first and worst affected areas in Europe. Modified diagnostic and treatment algorithms are proposed to adapt evidence-based protocols for this unprecedented challenge. Various clinical scenarios, as well as management algorithms for patients with a diagnosed or suspected COVID-19 infection, presenting with ST- and non-ST-segment elevation ACS are described. In addition, we address the need for re-organization of ACS networks, with redistribution of hub and spoke hospitals, as well as for in-hospital reorganization of emergency rooms and cardiac units, with examples coming from multiple European countries. Furthermore, we provide a guidance to reorganization of catheterization laboratories and, importantly, measures for protection of healthcare providers involved with invasive procedures.
参考来源
- Chieffo A, Stefanini GG, Price S, et al. EAPCI Position Statement on Invasive Management of Acute Coronary Syndromes during the COVID-19 pandemic. Eur Heart J. 2020. PMID: 32405641. doi:10.1093/eurheartj/ehaa381
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。